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ABSTRACT Interfacial behavior was studied in pulmonary surfactant model systems containing an amphiphilic a-helical
peptide (Hel 13-5), which consists of 13 hydrophobic and ﬁve hydrophilic amino acid residues. Fully saturated phospholipids
of dipalmitoylphosphatidylcholine (DPPC) and dipalmitoylphosphatidylglycerol (DPPG) were utilized to understand speciﬁc inter-
actions between anionic DPPG and cationic Hel 13-5 for pulmonary functions. Surface pressure (p)-molecular area (A) and
surface potential (DV)-A isotherms of DPPG/Hel 13-5 and DPPC/DPPG (4:1, mol/mol)/Hel 13-5 preparations were measured
to obtain basic information on the phase behavior under compression and expansion processes. The interaction leads to a vari-
ation in squeeze-out surface pressures against a mole fraction of Hel 13-5, where Hel 13-5 is eliminated from the surface on
compression. The phase behavior was visualized by means of Brewster angle microscopy, ﬂuorescence microscopy, and atomic
force microscopy. At low surface pressures, the formation of differently ordered domains in size and shape is induced by elec-
trostatic interactions. The domains independently grow upon compression to high surface pressures, especially in the DPPG/Hel
13-5 system. Under the further compression process, protrusion masses are formed in AFM images in the vicinity of squeeze-out
pressures. The protrusion masses, which are attributed to the squeezed-out Hel 13-5, grow larger in lateral size with increasing
DPPG content in phospholipid compositions. During subsequent expansion up to 35 mN m1, the protrusions retain their height
and lateral diameter for the DPPG/Hel 13-5 system, whereas the protrusions become smaller for the DPPC/Hel 13-5 and DPPC/
DPPG/Hel 13-5 systems due to a reentrance of the ejected Hel 13-5 into the surface. In this work we detected for the ﬁrst time, to
our knowledge, a remarkably large hysteresis loop for cyclic DV-A isotherms of the binary DPPG/Hel 13-5 preparation. This
exciting phenomenon suggests that the speciﬁc interaction triggers two completely independent processes for Hel 13-5 during
repeated compression and expansion: 1), squeezing-out into the subsolution; and 2), and close packing as a monolayer with
DPPG at the interface. These characteristic processes are also strongly supported by atomic force microscopy observations.
The data presented here provide complementary information on the mechanism and importance of the speciﬁc interaction
between the phosphatidylglycerol headgroup and the polarized moiety of native surfactant protein B for biophysical functions
of pulmonary surfactants.INTRODUCTION
Pulmonary surfactant (PS) is a surface-active material that
lines the air/alveolar fluid interface in mammalian lungs. It
plays an important role in vital physiological processes,
such as respiratory movement. Its main function is to reduce
surface tension at the interface, preventing alveolar collapses
at the end-expired state and minimizing the work of
breathing (1). This function is achieved by the formation
of a surface-active film that consists of lipid monolayers
highly enriched in dipalmitoylphosphatidylcholine (DPPC),
and bilayer or multilayer structures (surface-associated reser-
voirs) closely attached to surface monolayers. These layered
structures below the surface monolayer were recently
confirmed in vitro by fluorescence microscopy (FM) and
atomic force microscopy (AFM) (2–5), and also in vivo by
electron microscopy (6).
PS is composedof lipids (~90wt%)andproteins (~10wt%).
The lipids consist mainly of phosphatidylcholines (especially
DPPC, ~50 wt %) and smaller but significant amounts of
phosphatidylglycerol (PG) and palmitic acid (PA) (7–9).
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0006-3495/09/02/1415/15 $2.00With respect to the proteins, the hydrophobic surfactant
protein B (SP-B) has a crucial role in lung functions. SP-B
deficiency caused by its gene knockout in mice (10) or by
its gene mutation in preterm infants (11,12) can lead to fatal
respiratory failure. Moreover, the genetic absence of SP-B
induces a deficiency in another hydrophobic surfactant
protein, surfactant protein C (SP-C), due to dysfunction of
the SP-C proprotein (10). The human SP-B contains 79 amino
acids and has a molecular mass of 8.7 kDa (13,14). SP-B has
a net charge of þ7, which is thought to be essential for
electrostatic interactions between its polar residues and the
headgroups of negatively charged phospholipids, such as
PG (4,15). Given the importance of SP-B for proper
PS activity, synthetic peptides based on the amino acid
sequence of SP-B have been designed to clarify the mecha-
nism of lipid-protein interactions around the interface and to
develop synthetic surfactant preparations containing artificial
peptides, such as KL4 (16–18) and Hel 13-5 (19–21), for
patients with respiratory distress syndrome (RDS). Hel 13-5
(NH2-KLLKLLLKLWLKLLKLLL-COOH) is a monomeric
synthetic peptide based on the N-terminal segment of human
SP-B. Its structure and surface activity have been investigated
thoroughly both in vitro and in vivo. The secondary
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(20,22). In vivo experiments showed that the PS preparations
containing Hel 13-5 improved lung function and activities in
surfactant-deficient rats more than Surfacten (Surfactant TA)
(23), which is an analog to Survanta (Ross Laboratories,
Columbus, OH). Surfacten is a bovine lung surfactant extract
supplemented with DPPC, PA, and tripalmitin, and is
commonly administered to RDS infants in Japan (24).
Fluid lipids with less ability to sustain high surface pres-
sures are preferentially ejected from the surface upon
compression to enrich the monolayers in rigid phospholipids
(mainly DPPC) (25,26). In general, this behavior is known
as the ‘‘squeeze-out’’ phenomenon. The squeeze-out theory
classically assumes an idealized, immiscible interaction
between liquid-expanded (LE; unsaturated lipid components)
and liquid-condensed (LC; saturated lipid components)
monolayers. The phenomenon has a close relation to lung
surfactant functions such as the formation of surface-associ-
ated reservoirs at the adjacent interface and the hysteresis
property of respiratory movement. Moreover, it has strongly
affected the design of replacement PS preparations for RDS
treatment (27,28). However, it has never been made clear
how PS molecules perform such physiological and biophys-
ical functions, although structural evidence of the reservoirs
by means of electron microscopy has steadily been confirmed
(6). Conventionally, the squeeze-out theory based on the
immiscible interaction (or phase separation) has dominated
the interpretation of PS experiments. Recent studies have
provided new information on the mechanism of the squeeze-
out action, with a particular focus on the potential interaction
of SP-B with anionic PG (15,29–31). However, the contribu-
tions of the specific lipid-protein interaction to the squeeze-out
and the stability of surface-associated reservoirs are controver-
sial because of the bulkiness and structural complex of SP-B.
and the quite different resolutions between microscopic and
spectroscopic techniques.
In this study we focused our attention particularly on the
specific interaction between negatively charged phospho-
lipid and Hel 13-5 (SP-B mimicking peptide) with net
charges of þ5. The aim of this study was to elucidate the
effect of the specific interaction on in vitro lung functional
indices, such as the monolayer phase behavior and
morphology, the hysteresis properties of Langmuir
isotherms, and the stability of surface-associated reservoirs.
Therefore, we used fully saturated lipid systems to eliminate
a factor of the LE-LE (or disordered-disordered) attractive
interaction between them (26,32–35). We present the
isotherms, Brewster angle microscopy (BAM), FM, and
AFM for PS model preparations of dipalmitoylphosphatidyl-
glycerol (DPPG) and DPPC/DPPG (4:1, mol/mol) with and
without Hel 13-5 under the physiological condition of pH
and ionic strength. Recently, there has been increasing
interest in AFM, which yields stimulating information on
surface topography and the corresponding phase contrast
on a nanometer scale, thereby providing new insights intoBiophysical Journal 96(4) 1415–1429the interaction and biophysical activity of lipids and model
peptides during the breathing cycle. These results are
compared with previous data obtained in the same manner
for DPPC/Hel 13-5 systems to reveal the preferential interac-
tion of PG or PC headgroups with Hel 13-5 during the
successive compression and expansion process (20).
MATERIALS AND METHODS
Materials
Peptide synthesis and puriﬁcation
An SP-B mimicking peptide, Hel 13-5 (NH2-KLLKLLLKLWLKLLKLLL
COOH), was synthesized by Fmoc (9-fluorenylmethoxycarbonyl) chemistry
starting fromFmoc-(Leu or Lys)-PEG-PS (polyethylene glycol-polystyrene)-
resin (0.6 g, 0.12 mmol) in monitoring the deprotection of Fmoc group by
UVabsorbance. The resultant crude peptideswere passed through a Sephadex
G-25 gel filtration chromatography (25 mm  130 cm). Then the peptides
were purified by a preparative C8 HPLC column (20 mm  250 mm;
Cosmosil, nacalai tesque, Kyoto, Japan) with a gradient system of water-
acetonitrile containing 0.1% TFA. The purity was confirmed to be >98%
by means of an analytical C18 RP-HPLC column (4.6 mm  250 mm;
Cosmocil). The detailed procedures used for synthesis, purification, and basic
analysis of the Hel 13-5 peptides were reported previously (36).
Phospholipids and solvents
L-a-dipalmitoylphosphatidylcholine (DPPC; purity >99%) and L-a-
dipalmitoylphosphatidylglycerol (DPPG; purity >99%) were obtained
from Avanti Polar Lipids (Alabaster, AL). DPPG was supplied as its sodium
salt. 1-Palmitoyl-2-[6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl]-
sn-glycero-3-phosphocholine (NBD-PC) was also purchased from Avanti
Polar Lipids as a fluorescent probe. These lipids were used without further
purification or characterization. Chloroform (99.7%) and methanol
(99.8%) were used as spreading solvents and were obtained from Cica-
Merck (Uvasol, Tokyo, Japan) and nacalai tesque (Kyoto, Japan), respec-
tively. Tris(hydroxymethyl) aminomethane (Tris) and acetic acid (HAc) of
guaranteed reagent grade for the preparation of a subsolution were
purchased from nacalai tesque. Sodium chloride (nacalai tesque) was roasted
at 1023 K for 24 h to remove all surface-active organic impurities. The
substrate solution was prepared using thrice-distilled water (surface tension
¼ 71.96 mN m1 at 298.2 K and electrical resistivity ¼ 18 MUcm).
Methods
Surface pressure-area isotherms
The surface pressure (p) of the monolayers was measured using an automated
in-house-made Wilhelmy balance. The surface pressure balance (AG-64;
Mettler Toledo, Greifensee, Switzerland) had a resolution of 0.01 mN m1.
The pressure-measuring system was equipped with a filter paper (Whatman
541, periphery ¼ 4 cm, Whatman International, Maidstone, England). The
trough was made from Teflon-coated brass (area ¼ 750 cm2), and Teflon-
made barriers (both hydrophobic and lipophobic) were used in this study.
The compression process of a typical phospholipid, such as DPPC, can reach
surface pressures close to 70 mN m1 without leakage of materials by using
hydrophilic barriers. A collapse value of DPPC monolayers is a controversial
subject in the literature (37–42). Namely, an entire Teflon-made system is
possible to prevent adsorption ofmaterials to barriers and to elucidate quantita-
tive analyses up to monolayer collapse states of phospholipids exactly. In
this study, the first kink point on the p-A isotherms at higher surface pressures
(>50 mN m1) is defined as a monolayer collapse (37,38,40,41). The surface
potentialmeasurement also supports this behavior. Surface pressure (p)-molec-
ular area (A) isotherms were recorded at 298.2 K within  0.1 K. Stock
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prepared in chloroform/methanol (2/1, v/v). The spreading solvents were al-
lowed to evaporate for 15 min before compression. The monolayer was
compressed at a speed of <0.11 nm2 molecule1min1. Cyclic compression-
expansion isotherms (hysteresis curves) were drawn by tracing compression
and expansion processes alternately through five cycles at a rate of
~0.24 nm2 molecule1min1 (or ~90 cm2 min1). The standard deviations
(SDs) for molecular surface area and surface pressure were ~0.01 nm2 and
~0.1 mN m1, respectively. The pH of the subsolution was controlled with
0.02M Tris buffer and 0.13MNaCl, and was adjusted to 7.4 with an adequate
amount of HAc.
Surface potential-area isotherms
The surface potential (DV) was simultaneously recorded with surface pres-
sure where the monolayer was compressed and expanded at the air/water
interface. It was monitored by means of an ionizing 241Am electrode at
1–2 mm above the interface while a reference electrode was dipped into
the subsolution. The electrometer (Keithley 614 and 6517, Keithley Instru-
ments, Cleveland, OH) was used to measure the surface potential. The SD
for the surface potential was 5 mV (19,43,44).
Brewster angle microscopy
The monolayer was directly visualized by means of a Brewster angle micro-
scope (KSV Optrel BAM 300; KSV Instruments, Helsinki, Finland) coupled
to a commercially available film balance system (KSV Minitrough, KSV
Instruments Ltd., Finland). The application of a 20 mWHe-Ne laser emitting
p-polarized light of 632.8 nm wavelength and a 10 objective lens allowed
a lateral resolution of ~2 mm. The angle of the incident beam to the air/water
interface was fixed to the Brewster angle (53.1) at 298.2 K. The reflected
beam was recorded with a high-grade charge-coupled device (CCD) camera
(EHDkamPro02; EHD Imaging, Demme, Germany) and the BAM images
were digitally saved to the computer’s hard disk.
Fluorescence microscopy
The film balance system (KSV Minitrough) was mounted onto the stage of
the Olympus microscope BX51WI (Tokyo, Japan) equipped with a 100-W
mercury lamp (USH-1030L), an objective lens (SLMPlan50, working
distance ¼ 15 mm), and a 3CCD camera with a camera control unit
(IKTU51CU; Toshiba, Tokyo, Japan). The z-directional focus on the
monolayer was adjusted exactly with the use of an automation controller
(MAC 5000; Ludl Electronic Products, Hawthorne, NY). FM observations
and compression isotherm measurements were carried out simultaneously.
A spreading solution of the samples was prepared as a mixed solution doped
with 1 mol % of a fluorescence probe (NBD-PC). The excitation (460 nm)
and emission (534 nm) wavelengths were selected by a mirror unit
(U-MWIBA3). FM micrographs were directly recorded with the hard disk
via an online image processor (DVgate Plus; Sony, Tokyo, Japan) connected
to the microscope. Image processing and analysis were carried out with
Scion Image Beta 4.02 for Windows software (Scion, Frederick, MD).
The total amount of ordered domains (dark contrast regions) was evaluated
and expressed as a percentage per frame by dividing the respective frame
into dark and bright regions.
Atomic force microscopy
Langmuir-Blodgett (LB) film preparations were carried out with the KSV
Minitrough. Freshly cleaved mica (Okenshoji, Tokyo, Japan) was used as
a supporting solid substrate for the film deposition (a vertical dipping
method). At selected surface pressures, a transfer velocity of 5 mm min1
was used for the film-forming materials on a 0.02 M Tris buffer and 0.13 M
NaCl (pH 7.4) at 298.2 K. The transfer occurs such that the hydrophilic
part of the monolayer is juxtaposed to the mica while the hydrophobic part
is exposed to air. LB filmswith a deposition rate of ~1 were used in the exper-
iments. The AFM experiments were performed in the air. The LB technique
includes the possibility that the original monolayer structures are changed bythe electric charge of samples and the physical factor during the deposition
procedure. AFM images do not provide completely correct information on
the phase behavior at the air/water interface, but can provide helpful informa-
tion for understanding pulmonary functions. AFM images were obtained
using an SPA 400 instrument (SII, Chiba, Japan) at room temperature in
the tapping mode, which provided both a topographical image and a phase-
contrast image. The tapping-mode images (256 or 512 points per line) were
collected with scan rates of 1 Hz using silicon tips (Olympus, Tokyo, Japan)
with a nominal spring constant of 1.8 N m1 under normal atmosphere
(20,45). The lateral and vertical resolutionswere 0.2 and 0.1 nm, respectively.
The transferred samples were checked for possible tip-induced deformation
by zooming out after a region was scanned.
RESULTS AND DISCUSSION
Isotherm behavior
The surface pressure (p) measured by film balance is
commonly used to obtain information on a change in the sur-
face tension (g) with the surface concentration of the surfac-
tants. The relation between p and g is given by the equation
p ¼ g0  g, where g0 represents the surface tension of the
subsolution without monolayers. On the other hand, the
surface potential (DV) provides sensitive information on
molecular orientation and conformation normal to the inter-
face depending on the molecular area (A). Thus, coincidence
measurements of p-A and DV-A isotherms for PS systems
contribute to a better understanding of their action and func-
tion under compression and expansion. As shown in Fig. 1,
typical p-A and DV-A isotherms for fully saturated phospho-
lipid systems of DPPG and DPPC/DPPG (4:1, mol/mol),
whose ratio is the same as that found in a natural lung lavage
(13), were measured to obtain basic information on the phase
behavior of monolayers at the air/water interface. The p-A
isotherm of pure DPPG monolayers has a kink at ~17 mN
m1 (A¼ 0.70 nm2) corresponding to the first-order transition
from the LE to LC state. The collapse pressure of DPPG
monolayers is ~56 mN m1 (A¼ 0.39 nm2), where the trans-
formation of monolayer states (2D) into other states (3D)
occurs. The monolayer compressibility, Cs, for each sample
was calculated from p-A isotherms using Cs ¼ (1/A)(dA/
dp). The inverse compressibility, Cs1, is expressed against
p in the inset of Fig. 1 to distinguish inflection points on p-
A isotherms. The transition and collapse pressures indicated
by straight-line and dashed arrows, respectively, in Fig. 1
can be determined by analyzing the change in slope of both
p-A and DV-A isotherms, and the local minimum of Cs1-p
curves (19,45). In the case of the DPPC/DPPG lipid mixture,
the transition pressure is ~10mNm1 (A¼ 0.68 nm2) and the
mixture forms stablemonolayers up to ~57mNm1 (A¼ 0.39
nm2). In this system, the shape ofp-A isotherms is very similar
to that for DPPC monolayers reported previously because of
the DPPC-enriched contents (20). These p-A isotherms agree
well with the data in published studies (25,46,47).
The DV values of DPPG show large positive variations
from ~0 to ~402 mV upon lateral compression. The sharp
jump appears on the DV-A isotherm at ~1.25 nm2, whichBiophysical Journal 96(4) 1415–1429
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phases. On further compression after the jump, theDV values
reach the maximum value (~402 mV) via phase changes
from the LE phase through the LC phase to solid state.
The increase in DV value means an orientational improve-
ment of monolayers, and the close-packed monolayers
induced by compression generate the maximum DV value
with a subsequent plateau, which is characterized by
collapsed monolayers or a 3D solid state. The DPPC/
DPPG system exhibits a DV-A isotherm similar to that of
DPPG alone. However, DPPC/DPPG exerts the larger DV
values (~495 mV) in the close-packed state. This is ex-
plained by the fact that the DPPC/DPPG mixtures consist
mainly of DPPC, whose monolayer has the maximum DV
value of ~550 mV, as reported previously (20). Taking
into account that the surface density of the end-tail CH3–
group in the close-packed state is almost the same among
DPPG, DPPC/DPPG, and DPPC monolayers due to the satu-
rated hydrophobic chains, the difference in maximum DV
FIGURE 1 Surface pressure (p)-molecular area (A) and surface potential
(DV)-A isotherms of pure DPPG and DPPC/DPPG (4:1, mol/mol) mono-
layers under compression in a 0.02 M Tris buffer solution (pH 7.4) with
0.13 M NaCl at 298.2 K. Their inverse compressibility, Cs1, against p is
inserted. The LE/LC transition and monolayer collapse pressures are indi-
cated by straight-line arrows and dashed arrows, respectively.Biophysical Journal 96(4) 1415–1429values is attributed to differences in the headgroup of phos-
pholipids (48–50).
As reported previously (5,19,20), Hel 13-5 alone has no
kink point and is more expanded, indicating that the Hel
13-5 monolayer is in the disordered state over the whole
surface pressure. Therefore, Hel 13-5 forms the disordered
film up to ~42 mN m1 (~2.0 nm2), and the extrapolated
area of Hel 13-5 is ~2.6 nm2, reflecting mainly a-helical
structures rather than b-sheet and other conformations
(5,22). The DV values of Hel 13-5 monotonically increase
to ~380 mV under compression, meaning that there is an
increase in its surface concentration with no orientational
change on lateral compression.
The isotherms for DPPG and DPPC/DPPG (4:1, mol/mol)
preparations containing various molar amounts of Hel 13-5
peptides (XHel 13-5) were examined to elucidate a variation
of fundamental properties by the addition of Hel 13-5 at the
air/water interface, and the representative data are shown in
Fig. 2, A and B, respectively. For the DPPG/Hel 13-5 prepara-
tions, all of the p-A isotherms (Fig. 2 A) have an LE/LC tran-
sition pressure of ~17 mNm1, as indicated by a straight-line
arrow. The pressure values of the transition are almost the
same as ~17 mN m1 in the range of 0 % XHel 13-5 % 0.1.
On the other hand, the p-A isotherms for DPPC/DPPG/Hel
13-5 indicate a smaller transition value of ~10 mN m1 over
the molar range (XHel 13-5) from 0 to 0.05, and a slight increase
in the value (~13mNm1) is observed for monolayers of XHel
13-5 ¼ 0.1. The above results indicate that the interaction
between the lipids and Hel 13-5 is very weak at low surface
pressures, similar to results obtained in previous systems
(5,19,20). At higher surface pressures, both of the p-A
isotherms at XHel 13-5 ¼ 0.1 have a plateau (indicated by
dashed arrows) where Hel 13-5 starts to be gradually
squeezed out of the monolayers. There is an obvious differ-
ence in the squeeze-out pressure between both themonolayers
of XHel 13-5 ¼ 0.1; ~50 mN m1 for DPPG/Hel 13-5 and
~42 mN m1 for DPPC/DPPG/Hel 13-5. Considering the
previous results from the PS preparations without abundant
PG components, the squeeze-out pressure on p-A isotherms
indicates a constant value of ~42 mN m1 corresponding to
the collapse pressure of single Hel 13-5 monolayers regardless
of compositions and components (5,19,20).As shown inFig. 3,
however, the binary preparations enriched in DPPG show
a variation of the squeeze-out pressures (range: 39–49 mN
m1) against XHel 13-5, whereas the pressures are kept almost
constant for DPPC/Hel 13-5 and DPPC/DPPG/Hel 13-5 with
a maximum deviation of 5 mN m1. The variation demon-
strates that cationic Hel 13-5 electrostatically interacts with
anionic DPPG at high surface pressures, similarly to miscible
behavior between normal lipid monolayers (45,51–53); that
is, the positive change in pressure at XHel 13-5 ¼ 0.1 suggests
that the mutual electrostatic attractive force prevents Hel 13-5
from being squeezed out of DPPG/Hel 13-5 monolayers.
At surface pressures below the plateau, the DV-A
isotherms for both preparations (Fig. 2, A and B) shift to
Speciﬁcity in Model Lung Surfactant 1419FIGURE 2 Representative compression p-A and DV-A
isotherms of (A) binary DPPG/Hel 13-5 and (B) ternary
DPPC/DPPG (4:1, mol/mol)/Hel 13-5 preparations in
a 0.02 M Tris buffer solution (pH 7.4) with 0.13 M NaCl
at 298.2 K. The isotherms are displayed as a function of
Hel 13-5; XHel 13-5 ¼ 0, 0.01, 0.025, 0.05, and 0.1. The
typical LE/LC transition pressures are indicated by
straight-line arrows. The onset of a plateau corresponding
to the squeeze-out motion of Hel 13-5 is indicated by
dashed arrows.larger DV values with increasing Hel 13-5 content. This is
attributed to a monotonous increase in DV value for a single
Hel 13-5 monolayer on compression (5,19,20). On further
compression beyond the plateau on p-A isotherms, however,
DV-A isotherms finally converge to similar DV values of
~402 (for DPPG/Hel 13-5) or ~495 mV (for DPPC/DPPG/
Hel 13-5), corresponding to the maximum values of the
respective lipids without Hel 13-5. This suggests that in
the high surface pressure region above the plateau, large
proportions of Hel 13-5 are squeezed out and the close-
packed monolayers composed mainly of lipid components
are formed at the surface.
In situ BAM observations
FM requires a small addition of a fluorescent probe to target
monolayers. The probe molecules behave like an impurity
and thusmay affect the filmmorphology andphase transitions.
On the other hand, BAM, which needs no fluorescent probe
and is sensitive to the surface density and anisotropy of phase
domains in a monolayer, can be used to avoid this drawback
and to confirm the data obtained from FM (45,54). The
in situ direct observation of monolayers with BAM has an
advantage in analyzing the correct (or original) phase behavior
upon lateral compression, although the practical resolution
and magnification achieved with BAM are much less
compared to those achieved with FM for our system. BAM
images represent differences in the local refractive index at
the interface due to variations in monolayer density, orienta-
tion, and structure. The representative BAM images for the
DPPG/Hel 13-5 systems at selected surface pressures are
shown in Fig. 4. For pure DPPG monolayers, homogeneous
dark images (Fig. S1 in the SupportingMaterial) are observed
below the transition pressure of ~17 mN m1. Small circular
LC domains of DPPG emerge at ~17 mN m1 and grow in
size by further compression above the transition pressure(Fig. 4, left row). Consequently, the images become homoge-
neously bright (Fig. S1), corresponding to LC (or solid)
phases. The BAM images for pure DPPG monolayers at
elevated surface pressures are similar to those reported previ-
ously (47). When a small amount of Hel 13-5 is added to
DPPG monolayers, the LC domains become quite small in
size and dispersed. In the case of the DPPC/DPPG/Hel 13-5
preparations, on the other hand, the effects of the Hel 13-5
addition on the phase behavior of theDPPC/DPPGmonolayer
can be visualized (Fig. 5). Compared to the BAM images of
DPPG alone, the DPPC/DPPG lipid mixture forms larger
LC domains with some branches such as a dendrimer (see
Figs. 4 and 5) and shows similar phase behavior and growth,
i.e., the LC domains shrink in size, keeping the similar domain
FIGURE 3 Surface pressures of the onset of the plateau against a molar
amount of Hel 13-5 (XHel 13-5) for DPPG/Hel 13-5, DPPC/DPPG (4:1, mol/
mol)/Hel 13-5, and DPPC/Hel 13-5. The plots indicate the surface pressure
values of means  SD; the maximum SD is 0.2 mN m1 for XHel 13-5 ¼
0.7 (DPPG/Hel 13-5). Note that the error bars are includedwithin themarkers.
The data for DPPC/Hel 13-5 were obtained from a previous study (20).Biophysical Journal 96(4) 1415–1429




DPPG XHel 13-5=0.01 XHel 13-5=0.025
FIGURE 4 Characteristic BAM
images of the binary DPPG/Hel 13-5
preparations at XHel 13-5 ¼ 0 (DPPG),
0.01, and 0.025 at selected surface pres-
sures in a 0.02 M Tris buffer solution
(pH 7.4) with 0.13 M NaCl at 298.2 K.
The scale bar in the lower-right corner
represents 50 mm.shape as Hel 13-5 content increases. The BAM images for
DPPC/DPPG/Hel 13-5 indicate that the electrostatic interac-
tion between DPPG and Hel 13-5 is negligible for the domain
shape as well as the nucleation process of the LC domains at
low surface pressures, due to lower surface concentrations of
DPPG compared to the binary system (Fig. 4).
In situ FM observations
Surface textures observed by FM during lipid phase transi-
tions of the model PS systems demonstrate the good perfor-
mance of surface characteristics. The LE/LC transition can
be analyzed by screening the distribution of fluorescent
probes in lipid monolayers. The contrast of FM images
depends on the difference in solubility of the probes between
LE (disordered) and LC (ordered) phases. As a result, the
probe molecules are selectively dissolved in LE phases. As
mentioned above, there remains the possibility that the probesBiophysical Journal 96(4) 1415–1429will affect the original phase behavior of the monolayers.
However, the presence of 1 mol % NBD-PC as a fluorescent
dye has no influence on the original p-A and DV-A isotherms
or the domain shapes in BAM images. Shown in Fig. 6 are the
selected FMmicrographs of theDPPG/Hel 13-5 preparations.
For pure DPPG monolayers, the phase behavior and domain
shape are quite similar to those obtained from BAM. With
increasing surface pressure from 17 to 25 mN m1 (Fig. 6,
left column), the ratio of LC (dark) domains per image
increases from 27% to 78%, which indicates the drastic trans-
formation to LC phases. On further compression beyond
35 mN m1, the proportion is kept constant at ~100% up to
the monolayer collapse (data not shown). The resultant phase
behavior and domain shape of pure DPPG monolayers are
similar to those reported previously (31). FM images of Hel
13-5 alone are homogeneously bright over the whole surface




DPPC/DPPG XHel 13-5=0.01 XHel 13-5=0.025
FIGURE 5 Characteristic BAM
images of the ternary DPPC/DPPG
(4:1, mol/mol)/Hel 13-5 preparations at
XHel 13-5 ¼ 0 (DPPC/DPPG), 0.01, and
0.025 at selected surface pressures in
a 0.02 M Tris buffer solution (pH 7.4)
with 0.13 M NaCl at 298.2 K. The scale
bar in the lower-right corner represents
50 mm.
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DPPG XHel 13-5=0.01 XHel 13-5=0.025
FIGURE 6 Representative FM images of the binary
DPPG/Hel 13-5 preparations at XHel 13-5 ¼ 0 (DPPG),
0.01, and 0.025 at selected surface pressures in a 0.02 M
Tris buffer solution (pH 7.4) with 0.13 M NaCl at
298.2 K. Percentages (%) refer to the ratio of ordered
domains in the micrograph. The monolayers contain
1 mol % fluorescent probe (NBD-PC). The scale bar in
the lower-right corner represents 100 mm.As for the phase behavior of the DPPG/Hel 13-5 preparations,
unique trends are observed by the systematical FM examina-
tion, which cannot be found by BAM for our system. Unfor-
tunately, this is due to the lower magnification and resolution
of the BAM apparatus compared to the FM one. Over the
range of 0<XHel 13-5% 0.01, the LC domains of DPPG grad-
ually andmonotonously shrink in sizewith increasingXHel 13-5,
as seen from the reduction in LC percentages. This shows that
at low and middle surface pressures, the electrostatic interac-
tion between the two molecules is very weak for the change
in the phase behavior, nucleation process, and domain shape
due to low surface concentrations of Hel 13-5. In the 0.01 <
XHel 13-5% 0.05 range, FM images show two kinds of nonflu-
orescent domains (indicated by straight-line and dashed
arrows in Fig. 6) at XHel 13-5 ¼ 0.025 (17 mN m1).
When the molar fractions of Hel 13-5 decrease from 0.025,
the two populations are observed up to XHel 13-5 ¼ 0.013, as
seen in Fig. S2; that is, the phase behavior for the DPPG/
Hel 13-5 monolayers varies on the border of XHel 13-5 ¼
0.01. The smaller domains indicated by the dashed arrow
are not intermediate to the larger ones, and the two domains
above grow independently in size and numberwith an increase
in surface pressure. As Hel 13-5 contents increase from
XHel 13-5¼ 0.025 to0.05, the ratio of the larger domains reduces
and the smaller domains come to dominate the images (data not
shown). Assuming nomutual interaction, the percentage of LC
domains should be expected to monotonously decrease
with increasing XHel 13-5. However, the percentages between
XHel 13-5¼ 0.01 and 0.025 remain almost the same. This irreg-
ular behavior implies the existence of a specific interaction
between DPPG and Hel 13-5 such as a a miscible monolayer.
For the FM images ofXHel 13-5¼ 0.01 and 0.025 at 17mNm1,the percentages are apparently rather different. However, they
regularly increase as the Hel 13-5 contents increase from XHel
13-5 ¼ 0.01 to 0.025 (Fig. S2). Thus, the smaller and larger
domains may consist of free DPPG molecules and DPPG/
Hel 13-5 complexes, respectively. There is a possibility that
the phase behavior observed here results from just a delayed
nucleation. If the smaller domains are characterized by a de-
layed nucleation, the domains should approach to the larger
domains indicated by the straight-line arrow (Fig. 6) with
increasing time. However, the smaller domains remain in the
images for up to 180 min (Fig. S3). Moreover, the smaller
domains do not vary in size and number to a large extent for
XHel 13-5 ¼ 0.025 (the DPPG/Hel 13-5 system) regardless of
a further increase in surface pressure (Fig. S4). Thus, it is
unlikely that the two populations can be attributed to the de-
layed nucleation in this system. At XHel 13-5R 0.1, the homo-
geneously bright images of disordered phases appear in FM for
our system regardless of surface pressures.
Representative FM images of the DPPC/DPPG/Hel 13-5
preparations are shown in Fig. 7. For the DPPC/DPPG
(4:1, mol/mol) lipid mixture, the FM images show phase
behavior similar to that obtained by BAM. The domain
shape is different from that of pure DPPG and DPPC (31),
which indicates that DPPC and DPPG form a miscible
monolayer. With increasing Hel 13-5 content, anticlockwise
LC domains of the lipid mixture shrink in size, and corre-
spondingly the ratio of LC domains gradually decreases at
20 mNm1. The irregular increase in the percentage at lower
surface pressures of 12 and 15 mN m1 is attributed to a
slight depression (<0.6 mN m1 in 0 % XHel 13-5 % 0.05)
of LE/LC transition pressures by the Hel 13-5 addition.
Here, the resultant FM images do not show the specificBiophysical Journal 96(4) 1415–1429
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DPPC/DPPG XHel 13-5=0.01 XHel 13-5=0.025
FIGURE 7 Representative FM images of the ternary
DPPC/DPPG (4:1, mol/mol)/Hel 13-5 preparations at
XHel 13-5 ¼ 0 (DPPC/DPPG), 0.01, and 0.025 at selected
surface pressures in a 0.02 M Tris buffer solution (pH
7.4) with 0.13 M NaCl at 298.2 K. Percentages (%) refer
to the ratio of ordered domains in the micrograph. The
monolayers contain 1 mol % fluorescent probe (NBD-
PC). The scale bar in the lower-right corner represents
100 mm.behavior that is observed in the binary DPPG/Hel 13-5 prep-
arations. This behavior would result from the fact that the
ratio of DPPG to Hel 13-5 is too small and/or that the
miscible interaction between DPPC and DPPG predominates
over the electrostatic interaction between DPPG and Hel
13-5. At pR 20 mN m1, the LC domains become irregular
in edge and confused. The change supports the latter aspect
for a balance of the two interactions; that is, with increasing
surface pressure, the electrostatic interaction becomes
stronger and stronger due to the shortened intermolecular
distance between DPPG and Hel 13-5, and thus DPPG can
interact with DPPC as well as Hel 13-5.
We previously proposed a ‘‘refluorescence’’ phenomenon
for FM observation of PS models, which provides what we
believe is novel morphological evidence of squeeze-out
events in Hel 13-5 (5,19).When pulmonary preparations con-
taining fluid lipids, such as anionic PG and dissociated pal-
mitic acid (PA), are observed by FM, the FM contrast clearly
varies before and after the squeeze-out of Hel 13-5 due to the
recovery from concentration quenching of FM probes. At the
stage of the squeeze-out event, Hel 13-5 is ejected together
with fluid components, including FM probes, and conse-
quently the surface concentration of FM probes decreases
to visualize the LE/LC coexistence again. In the preparations
used in this study, however, there is no variation in contrast
corresponding to the squeeze-out action, which means that
major parts of saturated DPPC and DPPG are not eliminated
from the surface, despite the squeeze-out of Hel 13-5.
Hysteresis behavior
During exhalation, fluid components in PSs are ejected from
the air/water interface to be stored in surface-associatedBiophysical Journal 96(4) 1415–1429reservoirs or 3D aggregates, preventing the alveolar
collapse. Under inhalation, on the other hand, the
squeezed-out molecules reenter with a delay and then spread
back into monolayers. This process is commonly called re-
spreading. The squeeze-out motion and respreading of the
fluid components generate a large hysteresis loop in typical
pressure-volume curves for lungs. Repeated compression-
expansion isotherm measurements on a trough allow us to
assess such biophysical functions in vitro for pulmonary
preparations. In particular, both the large hysteresis area
and reproducible hysteresis loops are very important for
pulmonary function and activity (55). To elucidate the
squeeze-out motion across the interface, a certain degree
of the plateau region is desired on p-A isotherms (55–57).
Therefore, we focus on the preparations of XHel 13-5 ¼ 0.1
in both the systems investigated above, which contain the
minimum amount of Hel 13-5. In addition, the data obtained
here were compared with those for the previous preparation
of DPPC/Hel 13-5 (XHel 13-5 ¼ 0.1) (20). Repeated cycling
p-A and DV-A isotherms of the preparations from the first
to the fifth rounds were measured. These monolayers were
compressed up to the respective collapse pressure and then
expanded to the starting molecular areas. This process was
successively repeated to elucidate the reproducibility of the
respreading process within a monolayer. For pure DPPG
(Fig. 8 A), both p-A and DV-A isotherms indicate a good
reproducibility from the first to the fifth cycles and a slight
hysteresis loop, as expected. This means that the variational
modes of molecular packing, surface concentration, and
orientation of monolayers depend simply on the molecular
area regardless of the difference in stage through the
compression-expansion cycle. On the other hand, the
DPPG/Hel 13-5 preparation (XHel 13-5 ¼ 0.1) exhibits large
Speciﬁcity in Model Lung Surfactant 1423FIGURE 8 Cyclic compression and expansion isotherms
of (A) pure DPPG and (B) the DPPG/Hel 13-5 preparation
at XHel 13-5 ¼ 0.1 on a 0.02 M Tris buffer solution (pH 7.4)
with 0.13 M NaCl at 298.2 K. The compression-expansion
cycle was performed five times at a compression rate of
~90 cm2 min1. Typical stages on hysteresis curves in B
are indicated by dashed arrows; (a) 35 mN m1, (b)
45 mN m1, and (c) 55 mN m1 during the compression
process; and (d) 45 mN m1 and (e) 35 mN m1 during
the expansion process.hysteresis loops on both p-A and DV-A isotherms (Fig. 8 B).
As mentioned above, the p-A hysteresis curves have a plateau
at high surface pressures (~50 mN m1) during lateral
compression, where the squeeze-out action and the subse-
quent formation of 3D aggregates adjacent to the interface
gradually occur. In addition, the collapse pressure is
enhanced compared to that of pure DPPG. This can be attrib-
uted to the stabilization of surface monolayers by the ejected
Hel 13-5 (5,19,20). In this case particularly, the electrostatic
interaction between the DPPG headgroup and the polarized
moiety of squeezed-out Hel 13-5 contributes to the stability.
Under expansion, the squeezed-out Hel 13-5 molecules
reenter the interface from the aggregates at the slower speed
relative to the expansion rate of movable barriers, resulting in
a rapid reduction of surface concentrations or surface pres-
sures (58). Thus, large hysteresis is generated on the cyclic
p-A isotherms. It is also notable that the DV-A isotherms
for the DPPG/Hel 13-5 preparation show large hysteresis
loops. As far as we know, hysteresis for cyclic DV-A
isotherms has never been reported, although a few articles
on DV-A isotherms for pulmonary preparations during
repeated compression and expansion have been published
(5,19,59). In this study, we detected for the first time, to our
knowledge, large hysteresis on the cyclic DV-A isotherms
for the DPPG/Hel 13-5 preparation. During compression,
the DV-A isotherms have a plateau corresponding to that on
the p–A isotherms (the region indicated by dashed arrow c
in Fig. 8 B). According to the conventional aspect, the plateau
on the DV-A isotherms means that the squeeze-out phenom-
enon of Hel 13-5 progresses mainly with same orientation
of DPPGmonolayers retained. However, the interpretation it-
self cannot explain why the hysteresis loop of DV-A
isotherms is produced especially for the DPPG/Hel 13-5
among the many kinds of PS preparations (5,19,20,23,59).Judging from the morphological phase behavior with FM
observations (XHel 13-5 ¼ 0.025; Fig. 6), the interfacial
behavior of Hel 13-5 in the squeeze-out region during
compression can be divided into the following two processes:
1), close packing as a monolayer with DPPG at the interface;
and 2), squeezing-out into the subsolution. Although these
two processes can be easily expected, they are completely
and evidently separated, which is caused by the electrostatic
interaction particularly in the binary system. In the plateau
region under compression, Hel 13-5 is preferentially elimi-
nated into the subsolution, with the molecular orientation of
surface monolayers kept almost constant, and the specific
interaction stabilizes both the squeezed-out Hel 13-5 beneath
the monolayers and the mixed monolayers with Hel 13-5 at
the interface. During expansion, the resultant packed mono-
layers above respread and then the molecular ordering and
orientation are released again along the expansion of molec-
ular area in the region of 0.40 nm2 < A% 0.70 nm2. In the
subsequent plateau (0.70 nm2 < A % 0.85 nm2), the
squeezed-out Hel 13-5 molecules stepwise reenter the surface
due to the low surface concentration of the monolayers. This
independent action is supported by the following facts: the
inclination of DV-A isotherms (0.40 nm2 < A % 0.70 nm2)
and the plateau (0.70 nm2< A% 0.85 nm2) in the expansion
process are considerably similar to those observed during
compression at 0.55 nm2 < A% 0.85 nm2 and 0.40 nm2 <
A% 0.55 nm2, respectively. These mechanisms can explain
why the large hysteresis is produced in the cyclic DV-A
isotherms.
For the DPPC/DPPG mixture without Hel 13-5 (Fig. 9 A),
both cyclic p-A and DV-A isotherms indicate similar
behavior to pure DPPG (Fig. 8 A). In contrast, the addition
of Hel 13-5 (XHel 13-5 ¼ 0.1) produces a hysteresis on both
p-A and DV-A isotherms for the DPPC/DPPG/Hel 13-5Biophysical Journal 96(4) 1415–1429
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of (A) DPPC/DPPG (4:1, mol/mol) and (B) the DPPC/
DPPG (4:1, mol/mol)/Hel 13-5 preparation at XHel 13-5 ¼
0.1 in a 0.02 M Tris buffer solution (pH 7.4) with
0.13M NaCl at 298.2 K. The compression-expansion cycle
was performed five times at a compression rate of ~90 cm2
min1. Typical stages on hysteresis curves in B are indi-
cated by dashed arrows; (a) 35 mN m1, (b) 45 mN m1,
and (c) 55 mN m1 during the compression process; and
(d) 45 mN m1 and (e) 35 mN m1 during the expansion
process.preparation (Fig. 9 B), just like the DPPG/Hel 13-5 system.
However, the hysteresis on both p-A and DV-A isotherms
is smaller in loop size than those of the binary mixture in
Fig. 8 B. In particular, the plateau on the DV-A isotherms
under compression is unclear or disappears. Furthermore,
the DPPC/Hel 13-5 preparation at XHel 13-5 ¼ 0.1 showed
the hysteresis on p-A isotherms, not on DV-A isotherms
(data not shown) (20). Although the preparations had the
same Hel 13-5 contents, a depression in the proportion of
DPPG was found to reduce hysteresis properties on p-A
and especially on DV-A isotherms, which suggests that an
appearance of the clear plateau and hysteresis on cyclic
DV-A isotherms indicates a specific interaction between
DPPG and Hel 13-5. This interaction contributes deeply to
pulmonary functions such as regulation of the squeeze-out
event, 3D aggregates, and orientation of surface monolayers.
As for the DPPC/Hel 13-5 system with no mutual electro-
static interactions (20), both of the above-mentioned
processes for Hel 13-5 were simultaneously carried out
during compression and expansion. Judging from these
hysteresis data, it is very possible that PG groups in PS
play a crucial role in the stabilization of surface-associated
reservoirs and the orientational control of surface mono-
layers by electrostatic interaction with cationic SP-B.
AFM observations
Lipid/peptide films were deposited onto mica, and the topog-
raphy and the corresponding phase contrast image were
subsequently visualized by AFM in tapping mode to investi-
gate the effect of the squeeze-out motion on phase behavior
under compression and to understand respreading of the
ejected Hel 13-5 under expansion. Here the systems of
DPPG, DPPC/DPPG (4:1, mol/mol), and DPPC containingBiophysical Journal 96(4) 1415–1429Hel 13-5 of XHel 13-5 ¼ 0.1 were examined as an LB
film. The hysteresis isotherm for the DPPC/Hel 13-5
(XHel 13-5 ¼ 0.1) monolayer was previously reported (20).
The LB films were fabricated at the desired surface pressures
indicated by dashed arrows (a–e) in Figs.8 B and 9 B. The
DPPC/Hel 13-5 films were deposited at the corresponding
surface pressures in the same manner. To investigate the
phase behavior of XHel 13-5 ¼ 0.1, whose ordered domains
were not detected by either BAM or FM, we obtained
AFM measurements for the systems. For the DPPG/Hel
13-5 preparation (Fig. 10, left column), the AFM height
image at 35 mN m1, where the squeeze-out has not yet
occurred, shows two different phases. Considering the diam-
eter of a-helical Hel 13-5 (~1.0 nm) and the height of non-
tilted phospholipids with saturated dipalmitoyl chains
(~2.5 nm) (20), bright networks and dark domains represent
DPPG and Hel 13-5 monolayers, respectively. The corre-
sponding phase-contrast image also exhibits the two phases
in an inverse contrast (data not shown). The height difference
between the two (0.9  0.2 nm) agrees well with the
theoretical one (see Table 1). Upon compression of the
monolayer, protrusion masses are formed at 45 mN m1, ap-
pearing as bright discs. The protrusions exist on DPPG
monolayers and the difference is 3.3  0.2 nm. According
to other AFM studies and previous work (3,20,26,32), the
protrusions are made of the ejected Hel 13-5 from surface
monolayers on compression. The intermediate state toward
the squeeze-out is indicated by arrows in Fig. 10. The
regions contain smaller protrusions with a height of 1.2 
0.3 nm. Hel 13-5 itself, with a collapse pressure of
~42 mN m1, has an intermediate state toward monolayer
collapse below its collapse pressure (20). Thus, the electro-
static interaction between the two may induce the formation
of the intermediate state even below the squeeze-out pressure
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FIGURE 10 Typical AFM topographic
images of DPPG/Hel 13-5, DPPC/DPPG
(4:1, mol/mol)/Hel 13-5, and DPPC/Hel
13-5 preparations at XHel 13-5 ¼ 0.1 in
a 0.02 M Tris buffer solution (pH 7.4)
with 0.13 M NaCl at 298.2 K. The mono-
layers for DPPG/Hel 13-5 and DPPC/
DPPG/Hel 13-5 were transferred onto
mica at (A) 35, (B) 45, and (C) 55 mN m1
upon first compression, as indicated by
dashed arrows in Figs. 8 B and 9 B, respec-
tively. For DPPC/Hel 13-5, the films were
deposited at the corresponding surface
pressures in the same manner. The scan
area is 1  1 mm and the scale bar in the
lower-right corner represents 200 nm.
The cross-sectional profiles along the scan-
ning line (white line) are given below each
column; 35 mN m1 (black line); 45 mN
m1 (red line); 55 mN m1 (blue line).
The height difference between the arrow-
heads is indicated in the cross-sectional
profile.(~50 mN m1). Film topography alters dramatically just
when the film is further compressed to 55 mN m1, where
Hel 13-5 has been squeezed out of the interface. In compar-
ison to the AFM images at lower surface pressures, the
domains of Hel 13-5 monolayers considerably reduce and
the protrusions increase in number and lateral size. The
protrusion height (3.1  0.6 nm) is very similar to that at
45 mN m1, corresponding to two to four layers of a Hel
13-5 molecule. Of interest, some of the protrusions tend tocome close together to form a clustered aggregate, like
a cloud.
In the case of the DPPC/DPPG/Hel 13-5 preparation
(Fig. 10, middle column), the AFM image at 35 mN m1
(below the squeeze-out pressure) shows the two different
contrasts similarly to that for the DPPG/Hel 13-5 system.
When the film is compressed beyond the squeeze-out pres-
sure of ~42 mN m1, the protrusions are formed on the
DPPC/DPPG monolayers (bright regions) and the domainsTABLE 1 Height differences obtained by AFM for DPPG/, DPPC/DPPG/, and DPPC/Hel 13-5 preparations
Compression Expansion
Surfactant model system at XHel 13-5 ¼ 0.1
35 mN/m 45 mN/m 55 mN/m 45 mN/m 35 mN/m
A B A B A B A B A B
DPPG/Hel 13-5 0.9 – 1.3 3.3 1.3 3.1 1.4 4.0 1.4 4.2
DPPC/DPPG/Hel 13-5 1.0 – 1.0 3.3 1.1 2.8 0.7 3.0 0.6 1.8
DPPC/Hel 13-5 0.9 – 0.9 1.0 0.6 2.5 0.6 0.9 0.7 1.1
Note that results are expressed as means [nm] with maximum SD 0.8 nm.
A: Height differences between phospholipids and Hel 13-5 within a monolayer.
B: Height differences between phospholipid monolayers and squeezed-out Hel 13-5.Biophysical Journal 96(4) 1415–1429
1426 Nakahara et al.D 45 mN m–1
200 nm
DPPG/                     DPPC/DPPG/                    DPPC/





FIGURE 11 Typical AFM topographic images of DPPG/
Hel 13-5, DPPC/DPPG (4:1, mol/mol)/Hel 13-5, and
DPPC/Hel 13-5 preparations at XHel 13-5 ¼ 0.1 in
a 0.02 M Tris buffer solution (pH 7.4) with 0.13 M NaCl
at 298.2 K. The monolayers for DPPG/Hel 13-5 and
DPPC/DPPG/Hel 13-5 were transferred onto mica at (D)
35 and (E) 45 mN m1 upon first expansion, as indicated
by dashed arrows in Figs.8 B and 9 B, respectively. For
DPPC/Hel 13-5, the films were deposited at the correspond-
ing surface pressures in the same manner. The scan area is
1  1 mm and the scale bar in the lower-right corner repre-
sents 200 nm. The cross-sectional profiles along the scan-
ning line (white line) are given below each column;
35 mN m1 (black line); 45 mN m1 (red line). The height
difference between the arrowheads is indicated in the cross-
sectional profile.of Hel 13-5 monolayers decrease to a large extent in the LB
film of 45 mN m1. Then, at 55 mN m1 the protrusion
masses increase in number and lateral size to form a disc-
like particle tens of nanometers in diameter. For the DPPC/
Hel 13-5 preparation (Fig. 10, right column), phase behavior
similar to that of the other systems is also observed before
and after the squeeze-out pressure (~42 mN m1). However,
the protrusions observed at 45 and 55 mN m1 differ consid-
erably in shape and number. At 55 mNm1, in particular, the
squeezed-out Hel 13-5 has a tendency to disperse to form
a dot-like aggregate.
Judging from the AFM images at 55 mN m1, the lateral
size of the aggregates formed differs among the three prepa-
rations described above, although all of them exhibit protru-
sions with a similar height of ~3.0 nm. In addition, the
masses of the ejected Hel 13-5 disperse and become smaller
in lateral size with a decrease in DPPG content of the prep-
arations. Given that the preparations shown in Fig. 10
contain the equimolar Hel 13-5 (XHel 13-5 ¼ 0.1), it is
strongly suggested that the electrostatic interaction between
DPPG and Hel 13-5 plays an important role in the lateral
growth and organization of squeezed-out products at high
surface pressures. The surface concentration of monolayers
with anionic charges may control stabilization of the ejected
Hel 13-5.
Shown in Fig. 11 are the AFM height images of the LB
films described above for DPPG, DPPC/DPPG (4:1, mol/
mol), and DPPC with Hel 13-5 (XHel 13-5 ¼ 0.1) under
the first expansion cycle. As for the DPPC/DPPG/Hel 13-5
(middle column) and DPPC/Hel 13-5 (right column) prepa-
rations, the protrusions become smaller in diameter and
number, and correspondingly the dark regions of Hel 13-5
monolayers increase with decreasing surface pressureBiophysical Journal 96(4) 1415–1429from 45 to 35 mN m1. In addition, the height of the protru-
sions becomes <2.0 nm (Table 1). It is notable that the
height of protrusions for DPPC/Hel 13-5 approaches ~1.0 nm
rapidly at 45 mN m1 under expansion. On the other hand,
a gradual reduction in height is observed for DPPC/DPPG/
Hel 13-5. These results reveal that the respreading of the
squeezed-out Hel 13-5 is improved along the expansion
cycle. In the case of the DPPG/Hel 13-5 system (Fig. 11,
left column), however, there is a clear difference in phase
behavior compared to the other mixtures. Despite the
decreasing surface pressure (down to 35 mN m1), the
protrusions continue to retain their shape and size laterally
and vertically. This means that the ejected Hel 13-5 mole-
cules do not reenter the interface, but are kept below the
DPPG monolayer for a while after the films expand. It is
demonstrated that the squeezed-out Hel 13-5 is stabilized
beneath the interface under expansion by the electrostatic
interaction with the surface DPPG monolayers. Accord-
ingly, the surface monolayers are restricted to some extent
by the ejected Hel 13-5. This retention of the protrusions
strongly supports the notion that the independent emergence
of the eliminated Hel 13-5 to the surface takes place after
the relaxation of surface monolayers under expansion
(Fig. 8 B).
As for the DPPG/Hel 13-5 preparation, where Hel 13-5 is
surrounded by abundant anionic DPPG, the characteristic
behavior induced by the electrostatic interaction is made
clear by the results obtained here. Scheme 1 provides
a possible explanation for the interaction under film expan-
sion. Considering the saturated acyl chains of DPPG and
the results of compression isotherms (Fig. 2), major parts
of DPPG would not be ejected together with Hel 13-5, but
would remain at the interface as a monolayer during the
Speciﬁcity in Model Lung Surfactant 1427squeeze-out process. In previous studies that used pulmonary
preparations containing PG with unsaturated chains, the PG
components were squeezed out of surface monolayers
together with Hel 13-5 (5,19). At low surface pressures,
the electrostatic interaction is very weak due to the long
intermolecular distance between DPPG and Hel 13-5. The
lateral compression of the films reduces the above distance
within the monolayer state and the interaction accordingly
becomes stronger, resulting in variation of the squeeze-out
pressure (Fig. 3). Upon further compression beyond the
squeeze-out pressure, Hel 13-5 is preferentially eliminated
from the interface and forms mass aggregates like surface-
associated reservoirs beneath the surface DPPG monolayers
(Scheme 1 A). The aggregates are larger in lateral size
compared with the other preparations (Fig. 10). Therefore,
the electrostatic interaction contributes to the formation
and stabilization of the aggregates. During the expansion
cycle, the surface monolayers respread to the interface,
where the ejected Hel 13-5 is kept beneath the monolayers
(Scheme 1 B). Then, when the surface concentration of
monolayers decreases to a proper extent, the squeezed-out
Hel 13-5 molecules reenter the surface (Scheme 1 C). The
squeezed-out Hel 13-5 is stabilized by the negatively
charged headgroup of DPPG monolayers to stay longer
beneath the interface, especially in the binary system. Conse-
quently, the specific interaction generates larger hysteresis
loops on the cyclic p-A and DV-A isotherms compared to
the other preparations as shown in Fig. 8 B.
CONCLUSIONS
In this work, PS model preparations containing a synthetic
peptide (Hel 13-5) were investigated to clarify the importance
of the specific interaction between anionic phospholipid of
DPPG and cationic Hel 13-5 for pulmonary functions. In
particular, fully saturated phospholipid systems were utilized
to eliminate the miscibility behavior between phospholipids
and Hel 13-5, such as a disordered-disordered attractive inter-
action, as a factor. At low surface pressures, DPPG/Hel 13-5
monolayers form two kinds of ordered domains with different
diameters induced by the mutual electrostatic interaction, and
then the domains grow independently upon compression in
FM images. In the DPPC/DPPG/Hel 13-5 preparation, the
electrostatic interaction, which competes with the miscible
interaction between DPPC and DPPG within a monolayer,
becomes larger upon compression due to the shorter distance
between DPPG and Hel 13-5 molecules. In addition, the exis-
tence of the interaction is supported by the variation in the
squeeze-out pressure against a molar amount of Hel 13-5 in
the binary DPPG/Hel 13-5 preparation only. All of the prep-
arations indicate hysteresis loops on cyclic p-A isotherms,
where the loop size depends on DPPG contents in the surface
films. Of interest, the large hysteresis was first detected for the
cyclic DV-A isotherms in DPPG/Hel 13-5, not in DPPC/Hel
13-5 andDPPC/DPPG/Hel 13-5. The large hysteresis demon-strates that the mutual specific interaction triggers completely
independent processes for Hel 13-5 during repeated compres-
sion and expansion processes: 1), squeezing-out into subsolu-
tion; and 2), close packing as a monolayer with DPPG at the
interface. Judging from the new findings from AFM observa-
tions, the electrostatic interaction contributes to the aggrega-
tion of the squeezed-out Hel 13-5 molecules below the mono-
layers in lateral diameter under the compression process, and
to their stabilization up to low surface pressures under the
expansion process, which is special for the DPPG/Hel 13-5
system. This work systematically confirms the presence of
specific interactions between the PG headgroup and the
SCHEME 1 Possible explanation for the specific interaction between
anionic DPPG and cationic Hel 13-5 in the model pulmonary system of
DPPG/Hel 13-5 during expansion. (A) the close-packed state before expan-
sion, (B) middle surface pressures (0.40 nm2 < A% 0.70 nm2 in Fig. 8 B),
and (C) low surface pressures (0.70 nm2 < A % 0.85 nm2 in Fig. 8 B).
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1428 Nakahara et al.polarized moiety of Hel 13-5. Furthermore, the results
obtained using PS model systems will be helpful for under-
standing specific interactions between anionic phospholipids
and native SP-Bwith regard to the physiological and biophys-
ical functions of PS.
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